The experimental analysis shows that HSP90α has increased expression level in lung cancer patients, and the ROC curve suggests that apart from HSP90α expression levels, other four tumour biomarkers such as CEA, NSE, SCC, and CYFRA21-1 can also be tested for the optimal diagnostic efficacy. This evidence concerns the gene HSP90AA1 and lung carcinoma.